Regeneron Pharmaceuticals Inc
XBER:RGO

Watchlist Manager
Regeneron Pharmaceuticals Inc Logo
Regeneron Pharmaceuticals Inc
XBER:RGO
Watchlist
Price: 128.94 EUR 0.71% Market Closed
Market Cap: 13.9B EUR

Profitability Summary

Regeneron Pharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Regeneron Pharmaceuticals Inc

Margins Comparison
Regeneron Pharmaceuticals Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
984.9B USD
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272.2B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
178.1B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
110.4B USD
Loading...
Loading...
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
87.9T KRW
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.3B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Regeneron Pharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
984.9B USD
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272.2B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
178.1B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
110.4B USD
Loading...
Loading...
Loading...
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
87.9T KRW
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.3B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Regeneron Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate